Proposed diagnostic criteria for the Brugada syndrome: consensus report.
Wilde
Arthur A M
AA
Experimental and Molecular Cardiology Group, Academic Medical Center, Amsterdam, and the Interuniversity Cardiology Institute, The Netherlands. a.a.wilde@amc.uva.nl
Antzelevitch
Charles
C
Borggrefe
Martin
M
Brugada
Josep
J
Brugada
Ramón
R
Brugada
Pedro
P
Corrado
Domenico
D
Hauer
Richard N W
RN
Kass
Robert S
RS
Nademanee
Koonlawee
K
Priori
Silvia G
SG
Towbin
Jeffrey A
JA
D000328:Adult; D000889:Anti-Arrhythmia Agents; D001145:Arrhythmias, Cardiac / Q000145:classification / Q000150:complications* / Q000175:diagnosis* / Q000235:genetics; D019571:Arrhythmogenic Right Ventricular Dysplasia / Q000175:diagnosis; D016757:Death, Sudden, Cardiac / Q000209:etiology* / Q000517:prevention & control; D003937:Diagnosis, Differential; D004562:Electrocardiography / Q000592:standards; D022062:Electrophysiologic Techniques, Cardiac; D005260:Female; D005799:Genes, Dominant; D006801:Humans; D008297:Male; D062554:NAV1.5 Voltage-Gated Sodium Channel; D021122:Protein Subunits / Q000235:genetics; D012306:Risk; D015222:Sodium Channels / Q000235:genetics*; D013575:Syncope / Q000209:etiology; D013577:Syndrome
D000889:Anti-Arrhythmia Agents; D062554:NAV1.5 Voltage-Gated Sodium Channel; D021122:Protein Subunits; C568320:SCN5A protein, human; D015222:Sodium Channels